Medicilon Appoints Dr. Qingcong Lin As President of Medicilon Usa Corp
03/11/24, 12:46 PM
Location
lexingtonIndustry
biotechnology
health care
Position
president
Medicilon officially appoints Dr. Qingcong Lin as President of Medicilon USA Corp, a significant step to deepen its global and strategic layout. Dr
Company Info
Location
lexington, massachusetts, united states
Additional Info
Medicilon was established in 2004. It is a leading CRO specializing in comprehensive preclinical research and development services in the field of biomedicine. It has established a comprehensive service; technology platform, which integrates compound synthesis, compound activity screening, structural biology, CMC, pharmacodynamics evaluation, pharmacokinetics and toxicological safety evaluation. On November 5, 2019, Medicilon was officially listed on the Science and Technology Innovation Board, becoming the first pharmaceutical CRO company to be listed on the board (Stock Code: 688202.SH).
Related People
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Lh
Lh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Qh
Qh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more